Dr. Bob DeMaria is giving a workshop to his patients on heart health. www.druglessdoctor.comDr. Bob DeMaria is giving a workshop to his patients on heart health. www.druglessdoctor.com1
Dr. Bob DeMaria is giving a workshop to his patients on heart health. www.druglessdoctor.com
A man resembling a penguin and a girl who is psyched to be on camera talk about Ahman Green and the Houstons chances (or not)...A man resembling a penguin and a girl who is psyched to be on camera talk about Ahman Green and the Houstons chances (or not) of becoming a winning franchise. - NFL - Houston...1
A man resembling a penguin and a girl who is psyched to be on camera talk about Ahman Green and the Houstons chances (or not)...
Ban on short selling set to expire tomorrow night, with CNBC's Charlie Gasparino & Steve Liesman.Ban on short selling set to expire tomorrow night, with CNBC's Charlie Gasparino & Steve Liesman.0
Ban on short selling set to expire tomorrow night, with CNBC's Charlie Gasparino & Steve Liesman.
Insight on the financial crisis and its impact on American business, with Jim Kaitz, Association for Financial Professionals ...Insight on the financial crisis and its impact on American business, with Jim Kaitz, Association for Financial Professionals president & CEO and CNBC's Erin Burnett.0
Insight on the financial crisis and its impact on American business, with Jim Kaitz, Association for Financial Professionals ...
Discussing what's next for the markets, with Mary Matts, Fifth Third Asset Mgmt.; Jim Oberweis, Oberweis Asset Mgmt.; and CNB...Discussing what's next for the markets, with Mary Matts, Fifth Third Asset Mgmt.; Jim Oberweis, Oberweis Asset Mgmt.; and CNBC's Dylan Ratigan & Maria Bartiromo.0
Discussing what's next for the markets, with Mary Matts, Fifth Third Asset Mgmt.; Jim Oberweis, Oberweis Asset Mgmt.; and CNB...
Discussing the implications the Wachovia deal has for the markets, with CNBC's Charlie Gasparino.Discussing the implications the Wachovia deal has for the markets, with CNBC's Charlie Gasparino.0
Discussing the implications the Wachovia deal has for the markets, with CNBC's Charlie Gasparino.